SMCI’s 12.8% Drop Looks Like a Cautious Reversion Entry

I view today’s −12.80% move to $26.54 as a potential overreaction, but not proof that the decline is finished; I have no data identifying its cause. The shares are already down 33.4% over three months and 31.6% over 12 months, while trading at just 6.0x trailing earnings and an estimated 4.1x FY 2027 earnings. Fundamentals remain strong on reported growth: Q3 revenue rose 297.5% and net income 847.3% year over year. But −$476M of quarterly free cash flow is a meaningful warning, and estimated EPS growth slows from 100.1% in FY 2027 to 6.5% in FY 2028. The median target of $45.00 offers substantial upside, though the $18.00 low target highlights risk. This move modestly improves the mean-reversion setup; I’m buying only a small position.